Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parecoxib for intestinal function recovery after pancreatoduodenectomy
ChiCTR2000037746Phase 4Recruiting
- Sponsor
- The Second Hospital of Hebei Medical University
- Start
- Aug 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of parecoxib in postoperative ileus (POI) and Postoperative gastrointestinal dysfunction (POGD) (2 arms), sponsored by The Second Hospital of Hebei Medical University. Primary endpoints: Time to first flatus and defecation, Nausea and vomiting and 5 more. Started Aug 2020; status: recruiting.
02
Drugs
parecoxib
03
Conditions
postoperative ileus (POI)Postoperative gastrointestinal dysfunction (POGD)
Beyond the preview
Go deeper on ChiCTR2000037746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000037746.